info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0141939 |
| CAS No | NA |
| Mol.F. | C19H20N6O3 |
| Mol.Wt. | 380.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141940 |
| CAS No | NA |
| Mol.F. | C26H32N6O5 |
| Mol.Wt. | 508.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141941 |
| CAS No | NA |
| Mol.F. | C29H30N8O6 |
| Mol.Wt. | 586.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141942 |
| CAS No | NA |
| Mol.F. | C30H32N8O6 |
| Mol.Wt. | 600.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141943 |
| CAS No | NA |
| Mol.F. | C17H19N5O4 |
| Mol.Wt. | 357.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141944 |
| CAS No | NA |
| Mol.F. | C8H9N3O3 |
| Mol.Wt. | 195.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141945 |
| CAS No | NA |
| Mol.F. | C8H7N3O5 |
| Mol.Wt. | 225.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141946 |
| CAS No | NA |
| Mol.F. | C27H26N8O6 |
| Mol.Wt. | 558.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141947 |
| CAS No | NA |
| Mol.F. | C29H31N7O5 |
| Mol.Wt. | 557.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141948 |
| CAS No | NA |
| Mol.F. | C27H27N7O5 |
| Mol.Wt. | 529.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141949 |
| CAS No | NA |
| Mol.F. | C27H27N7O5 |
| Mol.Wt. | 529.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141950 |
| CAS No | NA |
| Mol.F. | C27H28N8O4 |
| Mol.Wt. | 528.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141951 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O7 |
| Mol.Wt. | 466.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141952 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O7 |
| Mol.Wt. | 466.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141953 |
| CAS No | NA |
| Mol.F. | C24H30N2O4 |
| Mol.Wt. | 410.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141954 |
| CAS No | NA |
| Mol.F. | C13H18N6O2 |
| Mol.Wt. | 290.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
